[go: up one dir, main page]

ES2144005T3 - Procedimiento de diagnostico para determinar la propension al parto y el equipo de reactivos para el uso del mismo. - Google Patents

Procedimiento de diagnostico para determinar la propension al parto y el equipo de reactivos para el uso del mismo.

Info

Publication number
ES2144005T3
ES2144005T3 ES93914749T ES93914749T ES2144005T3 ES 2144005 T3 ES2144005 T3 ES 2144005T3 ES 93914749 T ES93914749 T ES 93914749T ES 93914749 T ES93914749 T ES 93914749T ES 2144005 T3 ES2144005 T3 ES 2144005T3
Authority
ES
Spain
Prior art keywords
propension
labor
same
diagnostic procedure
reagent equipment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93914749T
Other languages
English (en)
Inventor
Eeva-Marja Rutanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medix Biochemica Oy AB
Original Assignee
Medix Biochemica Oy AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medix Biochemica Oy AB filed Critical Medix Biochemica Oy AB
Application granted granted Critical
Publication of ES2144005T3 publication Critical patent/ES2144005T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

LA INVENCION SE REFIERE A UN METODO DE DIAGNOSTICO PARA DETERMINAR LA SUSCEPTIBILIDAD AL SUMINISTRO Y A UN KIT DE ENSAYO PARA ESTE FIN. SE DETECTA UNA CONCENTRACION A UN NIVEL BAJO PERO MAYOR QUE LA LINEA DE BASE DE UNA PROTEINA AGLUTINANTE DEL FACTOR DE CRECIMIENTO TIPO INSULINA 1 (IGFBP-1), QUE PUEDE LLEVAR A FUGARSE DE CELULAS DE MEMBRANA CADUCA, MEDIANTE UN ENSAYO INMUNOLOGICO DE UNA MUESTRA DE SECRECION VAGINAL.
ES93914749T 1992-06-29 1993-06-29 Procedimiento de diagnostico para determinar la propension al parto y el equipo de reactivos para el uso del mismo. Expired - Lifetime ES2144005T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI923025A FI94181C (fi) 1992-06-29 1992-06-29 Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus

Publications (1)

Publication Number Publication Date
ES2144005T3 true ES2144005T3 (es) 2000-06-01

Family

ID=8535548

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93914749T Expired - Lifetime ES2144005T3 (es) 1992-06-29 1993-06-29 Procedimiento de diagnostico para determinar la propension al parto y el equipo de reactivos para el uso del mismo.

Country Status (12)

Country Link
US (4) US20050136490A1 (es)
EP (1) EP0648335B1 (es)
JP (1) JP3014451B2 (es)
KR (1) KR100242876B1 (es)
AU (1) AU674327B2 (es)
CA (1) CA2139309C (es)
DE (1) DE69328301T2 (es)
DK (1) DK0648335T3 (es)
ES (1) ES2144005T3 (es)
FI (1) FI94181C (es)
NO (1) NO319886B1 (es)
WO (1) WO1994000765A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109374906A (zh) * 2018-10-23 2019-02-22 深圳市慧思基因科技有限公司 Igf-i及igfbp-1在检测卵子质量中的应用

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94181C (fi) * 1992-06-29 1995-07-25 Medix Biochemica Ab Oy Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
US5597700A (en) * 1994-04-28 1997-01-28 California Research, Llc Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
US6394952B1 (en) 1998-02-03 2002-05-28 Adeza Biomedical Corporation Point of care diagnostic systems
FI981049A7 (fi) * 1998-05-12 1999-11-13 Medix Biochemica Ab Oy Menetelmä ja koeväline kohdunkaulan kypsyyden arvioimiseksi IGFBP-1:n fosforyloiduilla isomuodoilla
MXPA05001832A (es) 2002-08-13 2005-08-16 N Dia Inc Dispositivos y metodos para detectar fluido amniotico en secreciones vaginales.
WO2004034056A2 (en) * 2002-10-08 2004-04-22 Tara Nylese Portable diagnostic device and method for determining temporal variations in concentrations
US20050191704A1 (en) * 2004-03-01 2005-09-01 Kimberly-Clark Worldwide, Inc. Assay devices utilizing chemichromic dyes
EP1778874B1 (en) 2004-07-30 2011-11-23 Adeza Biomedical Corporation Oncofetal fibronectin as a marker for cervical cancer
WO2012125641A1 (en) 2011-03-17 2012-09-20 Cedars-Sinai Medical Center Diagnostic biomarker to predict women at risk for preterm delivery
CN107727841B (zh) 2013-01-02 2021-05-25 凯杰科学有限责任公司 预测孕妇分娩时间的方法
US20160130553A1 (en) 2014-05-15 2016-05-12 Kellbenx Incorporated PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
US9677975B2 (en) 2014-10-31 2017-06-13 General Electric Company Systems and methods for aseptic sampling
US12202890B1 (en) 2014-11-07 2025-01-21 Kellbenx Incorporated Antibodies for detection and enrichment of fetal cells and their use
FR3048287B1 (fr) * 2016-02-26 2018-03-23 Biosynex Procede de detection d'accouchement imminent
US10935555B2 (en) 2016-12-22 2021-03-02 Qiagen Sciences, Llc Determining candidate for induction of labor
US10656164B2 (en) 2016-12-22 2020-05-19 Qiagen Sciences, Llc Screening asymptomatic pregnant woman for preterm birth
EP3786977A1 (de) 2019-08-29 2021-03-03 WPmed GbR Computerimplementiertes verfahren und elektronisches system zur prognose eines entbindungszeitpunkts

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738177A1 (de) * 1987-11-10 1989-05-18 Siemens Ag Vermittlungsknoten fuer die vermittlung von in datenpaketen uebertragenen datensignalen
CA1337394C (en) * 1987-11-17 1995-10-24 Nelson N. H. Teng Vaginal sample test and reagents
US5096830A (en) * 1987-11-17 1992-03-17 Adeza Biomedical Corporation Preterm labor and membrane rupture test
US4952517A (en) * 1988-02-08 1990-08-28 Hygeia Sciences, Inc. Positive step immunoassay
US5258287A (en) 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
US5037735A (en) * 1988-06-24 1991-08-06 Microgenics Corporation Visual discrimination qualitative enzyme complementation assay
EP0424416B1 (en) 1988-07-15 1995-07-19 Central Sydney Area Health Service Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
US5252459A (en) * 1988-09-23 1993-10-12 Abbott Laboratories Indicator reagents, diagnostic assays and test kits employing organic polymer latex particles
ES2102397T3 (es) * 1990-03-16 1997-08-01 Applied Research Systems Tratamiento de la enfermedad del ovario policistico.
FI86777C (fi) * 1990-12-31 1992-10-12 Medix Biochemica Ab Oy Foerfarande foer diagnosticering av bristningen av fosterhinnorna samt reagensfoerpackning foer anvaendning daervid
FI94181C (fi) * 1992-06-29 1995-07-25 Medix Biochemica Ab Oy Diagnostinen menetelmä synnytysajankohdan ennustamiseksi sekä siihen käytettävä reagenssipakkaus
US5597700A (en) * 1994-04-28 1997-01-28 California Research, Llc Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method
FI981049A7 (fi) 1998-05-12 1999-11-13 Medix Biochemica Ab Oy Menetelmä ja koeväline kohdunkaulan kypsyyden arvioimiseksi IGFBP-1:n fosforyloiduilla isomuodoilla

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109374906A (zh) * 2018-10-23 2019-02-22 深圳市慧思基因科技有限公司 Igf-i及igfbp-1在检测卵子质量中的应用

Also Published As

Publication number Publication date
FI94181C (fi) 1995-07-25
FI923025L (fi) 1993-12-30
FI94181B (fi) 1995-04-13
JP3014451B2 (ja) 2000-02-28
EP0648335A1 (en) 1995-04-19
DK0648335T3 (da) 2000-07-03
FI923025A0 (fi) 1992-06-29
CA2139309C (en) 2004-08-31
EP0648335B1 (en) 2000-04-05
US20050136490A1 (en) 2005-06-23
NO319886B1 (no) 2005-09-26
WO1994000765A1 (en) 1994-01-06
CA2139309A1 (en) 1994-01-06
US20100099117A1 (en) 2010-04-22
DE69328301D1 (de) 2000-05-11
US7892774B2 (en) 2011-02-22
US20090269782A1 (en) 2009-10-29
DE69328301T2 (de) 2000-09-14
KR100242876B1 (ko) 2000-03-02
NO945017D0 (no) 1994-12-23
KR950702308A (ko) 1995-06-19
NO945017L (no) 1994-12-23
AU674327B2 (en) 1996-12-19
US20120135432A1 (en) 2012-05-31
JPH07508344A (ja) 1995-09-14
AU4502393A (en) 1994-01-24

Similar Documents

Publication Publication Date Title
ES2144005T3 (es) Procedimiento de diagnostico para determinar la propension al parto y el equipo de reactivos para el uso del mismo.
DE3784382D1 (de) Ventil zur dichtheitspruefung eines steigrohres.
DE69631738D1 (de) Medizinische implantierbare Vorrichtung für elektrochemische Messungen von Bluteigenschaften
ES2110487T3 (es) Metodo de diagnostico para detectar la rotura de las membranas fetales y kit de ensayo que emplea.
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
FI910396A7 (fi) Veteen liukenematon reagenssi, nukleiinihappokoetin, testipakkaus sekä diagnostisia ja puhdistusmenetelmiä
DE3689490D1 (de) Elektronenstrahlprüfsonde zur Untersuchung integrierter Schaltungen.
DE59914830D1 (de) Verfahren und testbesteck zur beurteilung der oxid messung ihrer antiradikalen aktivität
DE69005840D1 (de) Analytisches Element zur Untersuchung des gesamten Blutes.
DK0670493T3 (da) Analyse til bestemmelse af protein i en biologisk prøve
ES2194116T3 (es) Procedimiento para detectar anticuerpos antipolimero y kit de prueba de diagnostico para uso como ayuda al diagnostico de las enfermedades relacionadas con silicona.
DE69230000D1 (de) Verfahren und testsatz zur messung von endogenen zytokinen
SE8802944L (sv) Material foer lapptestning
NO953770L (no) Analysemetode
IT8511647V0 (it) Un portacapillare per strumenti di analisi in specie di analisi del sangue e particolarmente percontapiastrine, con due camere coassiali
ES8705629A1 (es) Perfeccionamientos en un aparato de analisis para la deter- minacion optica de substancias en solucion
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
DE60035267D1 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
EA199800352A1 (ru) ПОЛИПЕПТИД ХЕМОКИНА β-8 (ВАРИАНТЫ) И СПОСОБ ЕГО ПОЛУЧЕНИЯ, КОМПОЗИЦИИ ПОЛИПЕПТИДОВ, ВЕКТОР, КЛЕТКА-ХОЗЯИН, АГОНИСТ И АНТАГОНИСТ, ВСЕ - УПОМЯНУТОГО ПОЛИПЕПТИДА, И СПОСОБ ИДЕНТИФИКАЦИИ ПОСЛЕДНЕГО, СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В Хк-β-8 (ВАРИАНТЫ), СПОСОБ ЛЕЧЕНИЯ БОЛЬНОГО, ИСПЫТЫВАЮЩЕГО ПОТРЕБНОСТЬ В ПОДАВЛЕНИИ Хк-β-8, СПОСОБ ДИАГНОСТИКИ ЗАБОЛЕВАНИЯ ИЛИ ПРЕДРАСПОЛОЖЕННОСТИ К ЗАБОЛЕВАНИЮ, ОБУСЛОВЛЕННОМУ НЕДОСТАТОЧНОЙ ЭКСПРЕССИЕЙ ПОЛИПЕПТИДА
ATE103005T1 (de) Probe zur diagnose von bakterien.
EA199901001A1 (ru) Бетаины, используемые в качестве адъювантов для проверки чувствительности и антимикробной терапии
ES2032459T3 (es) Procedimiento de caracterizacion de una pipeta de laboratorio y su correspondiente pipeta.
DK135688A (da) Fremgangsmaade til isolering af basalmembranproteiner fra vaev fra mennesker og dyr

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 648335

Country of ref document: ES